Since the sequence of the human genome is complete, the main issue is how to understand the information written in the DNA se quence. Despite numerous genomewide studies that have already been performed, the challenge to determine the function of genes, gene products, and also their interaction is still open. As changes in the human genome are highly likely to cause pathological con ditions, functional analysis is vitally important for human health.
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For many years there have been a variety of technologies and tools used in functional genome analysis. However, only in the past decade there has been rapid revolutionizing progress and improvement in highthroughput methods, which are rang ing from traditional realtime polymerase chain reaction to more complex systems, such as nextgeneration sequencing or mass spectrometry. Furthermore, not only laboratory investigation, but also accurate bioinformatic analysis is required for reliable scientific results. These methods give an opportunity for accu rate and comprehensive functional analysis that involves various fields of studies: genomics, epigenomics, proteomics, and inter actomics. This is essential for filling the gaps in the knowledge about dynamic biological processes at both cellular and organis mal level. However, each method has both advantages and limita tions that should be taken into account before choosing the right method for particular research in order to ensure successful study. For this reason, the present review paper aims to describe the most frequent and widelyused methods for the comprehen sive functional analysis.
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INTRODUCTION
Although human genomes are about 99.9% identi cal, the remaining 0.1% is the reason of difference between people caused by different variants. Since 2003, the complete sequence of human genome, its annotation and increased advancement of sequenc ing technologies (i. e., Sanger and Nextgenera tionsequencing; NGS) have provided all the neces sary conditions for the identification of all variants in human coding and noncoding sequence (1, 2). Although the technique for variant detection is now becoming a routine, the key question throughout many years concerns the function of detected vari ants. The resource of important information about functional genomics are several largescale pro jects, for instance, the ENCODE project, the main goal of which was to identify all the functional ele ments, including regulatory elements in both coding and noncoding regions(3). According to another, the 1000 Genomes Project, there are about 20,000-23,000 variants in synonymous and nonsynony mous regions of the human genome. Even though not all of them are functionally meaningful, 530-610 of the variants have functional impact by causing in frame deletions and insertions, premature stop co dons, frameshifts, or by disrupting splice sites (4). Despite numerous studies, scientists are still facing a huge challenge in unravelling what the sequence means and in deciding whether or not a found var iant is pathogenic. A pathogenic variant can lead to disease or cause a number of disorders. However, understanding of pathogenic mechanisms creates an opportunity to prevent severe consequences by devel oping novel diagnostic tools and by designing highly effective treatments for the disease (5, 6) . To achieve this aim it is necessary to perform largescale func tional genome analysis that involves different fields of study: genomics, epigenomics, transcriptomics, proteomics, and interactomics. In order to describe the functions of genes and proteins as well as to re search the relationship between the genotype and the phenotype, a large number of various methods, including model systems (e. g., CRISPRCas9), can be used (6) (7) (8) . However, every method has its ad vantages and disadvantages (they are summarized in the Table) . For this reason, the present paper aims to give a brief overview of the most common technol ogies and tools that could be applied for functional genome analysis, mainly of transcriptome.
FROM VARIANT DETECTION TO FUNC-TIONAL GENOME ANALYSIS
Variants in coding as well as noncoding genome sequence range from single nucleotide changes to large, microscopically visible, chromosomal aber ration. These variants may have a huge impact on the function of gene. They can be either beneficial (e. g., single nucleotide polymorphism; SNP) with no negative effect on the phenotype, or pathogen ic (e. g., nonsense variant) -resulting in a num ber of different disorders and diseases (9, 10) . Depending on the variant type and locus, there are numerous different genetic methods and tools for the variant detection. For example, due to its simplicity the most frequent method for the anal ysis of a large (>5 Mb) chromosomal aberration is karyotype analysis by using the GTG banding technique (11) . Other molecular genetic methods, such as microarraybased comparative genomic hybridization (aCGH) or fluorescent in situ hy bridization (FISH), should be applied for a more accurate analysis. However, these methods have some significant limitations: the aCGH does not detect mosaicism, balanced translocations and in versions, while the FISH requires specific probes (12, 13) . Moreover, for particular variant detec tion another molecular genetic methods might be applicable, which include restriction enzyme assay, Multiplex ligationdependent probe ampli fication (MLPA), even though many of the tests are based on the Polymerase chain reaction (PCR) and its variants (e. g., multiplex PCR) (14) .
Although researchers can easily plan their assay in the case of particular variants, they are facing some challenges in the study of unspecified variants (6) . Sequencing is considered to be the "gold standard" method for the identification of known as well as un specified variants in the genomic DNA. In accordance with the previous statement, the Sanger or NextGen eration Sequencing (NGS) techniques can be used (15, 16) . The concept behind these two methods is similar. During the polymerase chain reaction, which consists of several cycles of sequential DNA replication, DNA polymerase catalyzes the com plementary incorporation of fluorescentlylabeled deoxyribonucleoside 5'tri phosphates (dNTPs) into the DNA template. For each cycle, a colour of the labeled DNA fragment is recorded by a detec tor, thus determining nucleotide in the sequence.
The main difference between the conventional (i. e., Sanger) technology and the NGS is that the latter is not limited to a single DNA fragment but analyzes millions of fragments in massively parallel sequenc ing technology (17, 18) . These two sequencing me thods are widely used all over the world. Even so, it is considered that in a smallscale project it is more eligible to use the Sanger sequencing system because of its accuracy. On the other hand, in largescale projects this research method would be expensive and timeconsuming, therefore the NGS needs to be applied (19, 20) . General progress in technology achieved in some strategies of the nextgeneration DNA sequencing has a huge impact on genetic re search (2). Recently, the most widely used platforms have been Roche/454 Life Science, Applied Biosys tems SOLiD, and Illumina Genome Analyzer. An other DNA sequencing technology has been lately developed by Ion Torrent. Nevertheless, "sequenc ingbysynthesis" used by Illumina currently is one of the most popular NGS platform. First of all, a randomly fragmented DNA is ligated with specific adaptors and amplified by the use of PCR. Second ly, a performed DNA library should be immobilized on the beads or arrays, thus generating clusters of identical DNA fragments. These clusters are then read by sequential cycles of nucleotide incorpora tion, washing, and detection, where the number of the cycles eventually determines the read length (7, (19) (20) (21) . In order to understand the genome struc ture, function, or evolution, it is not enough to ob tain the DNA sequencing data through the NGS: but there is also a need for deep and precise analysis using bioinformatics approaches. The key path to successful sequence analysis is to align the sequence of interest with another sequence whose function is known (usually termed as the reference genome). It might be very useful when the gene function is un known but is evolutionary related to another gene whose function is defined. In such a case, it can be suspected that the unknown gene has the same or similar function. Furthermore, the sequences might be scanned in order to find the significant match es between the components of a sequence that have been previously described as having a huge impact on the genomics function (6, 22) . In order to com pare the data, it is necessary to search for information in different biomedical databases. One of the biggest sources of biomedical and genomic information is the NCBI (National Center for Biotechnology Infor mation), which provides access to other databases such as PubMed, Entrez Gene, OMIM, Variation Viewer, dbSNP, and others (23) .
EPIGENOMICS
For functional analysis, it is important to take epi genetic modifications such as DNA methylation and histone modifications into account, because they affect gene expression without any changes in the underlying DNA sequence (24) . DNA methylation, which usually occurs in the context of densely situated CpG dinucleotides (i. e., CpG islands), correlates with transcriptional suppres sion. In order to detect DNA methylation status, unmethylated cytosines are converted into ura cil by using sodium bisulfite, because methylated cytosine is resistant to this impact. Additional ly, methylationdependent restriction enzymes (MDRE) are highly effective for DNA methylation analysis. These enzymes, e. g., HpaII and MspI, recognize and simply digest the methylated DNA. Usually, MDRE or even more frequently used bi sulfite conversion is the first step for many subse quent methods such as methylationspecific PCR, sequencing, bead array, etc. (25) (26) (27) (28) .
Histone modifications -acetylation, phos phorylation, methylation, ubiquitination, and others -are another cause of epigeneticallyregu lated genes. Depending on the modification type and locus, gene expression can be either activat ed or repressed (29) . The most common method for the investigation of histone modifications is chromatin immunoprecipitation (ChIP) based on the interaction between the antigen (of associated with DNA target protein) and the antibody (spe cific to target modified protein). After the precip itation, the genomic DNA is released for further research hinged on microarray analysis (ChIP chip), sequencing (ChIPseq), or quantitative PCR. Although these methods are highthrough put, the dependence on a specific antibody some times limits the use of the ChIP (21, 30) .
TRANSCRIPTOMICS
When the human genome was fully sequenced, the focus of attention shifted towards identify ing and annotating its functional DNA elements, including those that regulate gene expression.
Identification of such elements is a vitally important step towards elucidating pathogenic pathways that affect human health (3, 6).
All the RNAlevel processes, including tran scription activation or inhibition, mRNA pro cessing, and its transport are regulated by dif ferent functional elements of the genomic DNA. Nevertheless, the highest regulation occurs at the transcriptional initiation level through several regulative elements, which are called the cisact ing regulatory sequence and transfactors (6, 31) . Transfactors such as transcription factors (TF), activators, and repressors (including coactivators and corepressors) interact with specific DNA re gions, i. e., cisacting regulatory sequence that in cludes core promoter (with a TATA box and other binding elements), proximal promoter, enhancer, silencer, insulator, and locus control region (LCR). Investigation of these regulatory elements may be a challenge for the scientists because of the diffi culties in identifying the position of transcription start sites (TSSs) and transcription factors bind ing sites (TFBSs) in the core promoter. However, there are several experimental and bioinformati cal approaches (31) . First of all, a comparative bi oinformatical approach is necessary for the study of the regulatory elements. This type of research is usually based on constructing alignments be tween orthologous sequences because sequence homology provides valuable evidences to gene function analysis (6, 32) . Nevertheless, a deeper understanding of regulatory elements requires laboratory investigations. It is believed that every TFBS could be detected by the abovementioned ChIP method. Theoretically, depending on immu noprecipitation of the target protein, the core pro moters, enhancers, silencers, insulators and LCRs could be determined (31) . Furthermore, epige netic markers can be helpful in detecting TSSs in the core promoter and enhancer loci, because TSSs of actively transcribed genes are marked by H3K4me3 and H3K27ac, while enhancers by H3K4me1 and H3K27ac (33) . Another very fre quent functional assay of the regulatory element is based on the transgenesis of a specific report ergene (e. g., the gene of the green fluorescent protein -GFP or luciferase) into the target regu latory sequence. After the translation, activity of the reportergene is measured, e. g., by fluores cence of the GFP, with the purpose to determine if the examined region contains elements that alter reportergene expression (31, 32) .
Substantial information about functional genomics can be obtained through the analysis of the messenger RNA (mRNR) or cDNA, which is copied from the mRNA by reverse transcription PCR. Therefore researchers often choose to test the mRNR or cDNA rather than DNA, because RNA analysis may be more eligible for a gene that has many small exons and it can also reveal abnor mal splicing (6) . For many years there have been some standard methods for measuring the mRNR expression: Northern blotting, serial analysis of gene expression (SAGE) as well as quantitative realtime PCR (qPCR) among them. The SAGE method is based on the conversion of an RNA molecule into a short unique tag, while North ern blotting -on hybridization with radioactive probe. This allows to perform quantitative analy sis by counting the number of tags and measur ing intensity of band, respectively. However, both these methods are characterized as lowthrough put (34, 35) . Nevertheless, for the mRNA quan titation and gene expression evaluation the "gold standard" is qPCR, which is fast, very sensitive, and highly reproducible. The principle of this method is that during the reverse transcriptional reaction, complementary singlestranded cDNA from the RNA template is synthesized. The cDNA is necessary for subsequent use in quantitative PCR (36) . The aim of this reaction is to measure fluorescence intensity that is directly proportional to the amount of cDNA in the sample (37) . There are two strategies for qPCR data analysis: absolute quantification (based on the calibration curve) and relative quantification (based on the compar ison with reference sample) (38) . For the relative gene expression level calculation, the most con venient way is comparative CT (or 2 ΔΔCT ) method. This method relies on comparing the CT values of the target and reference samples, using a reference (endogenous housekeeping) gene as the normal izer. Finally, the method results in the fold change of target gene expression relative to a reference sample, normalized to a housekeeping gene (39) .
Acceleration of highthroughput technologies such as cDNA microarray and RNA sequencing (RNAseq), which also provides the possibility of transcriptional characterization, very often replac es preceding methods (40, 41) . Results obtained by a cDNA microarray assay provide important ge nomewide information about the changes of gene expression in various cell lines and in different stages of development. This method is based on hybridization of fluorescently labelled cDNA with the particular oligonucleotides (probe) on the specific microarray. The amount of hybridiza tion recorded for a specific probe is proportional to the number of DNA fragments in the sample. In this way, the obtained absolute hybridization val ues give an opportunity to detect genetic variation in the human genome (41, 42) . Despite the great advantages of cDNA microarray, highthroughput RNA sequencing based on different NGS systems is also increasingly used. The RNA sequencing results in a number of short reads. Aligned to a reference genome, they produce a specific tran scription map that corresponds to the transcrip tional structure and gene expression level (43) . It means that this technique is appropriate for gene, transcripts (including alternative gene spliced transcripts), or allelespecific expression identifi cation. Moreover, it is possible to accurately meas ure translation of transcripts. As each method has both advantages and disadvantages, the last one is not an exception. The problems in RNAseq are often related with high sequence similarity be tween alternative spliced isoforms or difficulties in data analysis (44, 45) .
PROTEOMICS AND INTERACTOMICS
From the functional point of view, analysis of pro teomics and interactomics is as vitally important as previously described analysis of genomics, epi ge nomics, and transcriptomics, because some stud ies show that gene expression at DNA or mRNA levels is substantially unchanged, although it af fects the protein function and vice versa (46, 47) . Proteins perform a vast array of functions within organisms, though abnormal protein expression that occurs due to posttranscriptional modifica tions or protein interaction with another protein or nucleic acids disrupts cell function (48) .
Depending on the intent of the experiment, there are two wellknown strategies for protein quantification: immunoassays or antibodyfree detection methods. Immunoassay, such as the enzymelinked immunosorbent assay (ELISA), is a widelyused method due to its high sensitivity and strong specificity (49) . However, sometimes researchers can face the problem when no anti body exists for the protein of interest. In such cas es the solution is antibodyfree methods. Firstly, compared to onedimensional protein separation method, twodimensional gel electrophoresis (2 DE), which separates protein by two properties in 2D gels is more effective (50, 51) . However, the most common and comprehensive analyti cal tool for protein detection, identification, and quantification is mass spectrometry (MS) that measures masstocharge (m/z) ratio of ions. Ad vancement of MS gives an opportunity to achieve a greater throughput of samples with high accu racy and precision. Additionally, it is considered that MS methodology is rapid and reliable for largescale studies (52) (53) (54) . Furthermore, due to its advantages MS is very often combined with another technique. For instance, some studies consist of antibodybased purification and mass spectrometry analysis termed mass spectrometric immunoassay (MSIA) (55) .
An important step towards characterization of the protein function is the identification of the protein interaction network consisting of different proteins. The most frequent system for detection of interacting proteins in living yeast cells is the twohybrid system (Y2H). The aim of such investigation is to create genetically modified yeast strains on a selective medium. In such a sys tem, two interacting proteins bound to specific domains switch on polymerase II, which subse quently activate the transcription of a reporter gene, whose transcription leads to a specific phe notype (e. g., changed colour) (56) . Furthermore, proteins interact also with nucleic acids, DNA and RNA. In functional approach, the most important interactions are between DNA and transcription factors or regulatory elements. In the case of RNA, it is necessary to test interactions between this nucleic acid and ribosome, or other RNA bind ing proteins. The analysis of both DNAprotein and RNAprotein interactions is based on sim ilar techniques (57, 58) . Previously mentioned highthroughput immunoprecipitation of the nu cleic acid and protein complex is increasingly be coming the method of choice for the detection of TFBSs and histone modification. Subsequent mi croarray, or NGS analysis, enables the identifica tion of a particular locus, i. e., the region that is specifically interacting with the protein of interest. However, the main limitation of the ChIP method is the dependence on antibody specificity (59) .
FUNCTIONAL GENOMICS INTEGRATING MODEL SYSTEMS
Nowadays, by the use of highthroughput sequenc ing technologies it is possible to generate detailed catalogue of genetic variation. However, the main question concerns the relationship between the genotype and phenotype. In order to answer this question, it is not possible to perform function al research directly on human beings due to some bioethical aspects. So there should be applied exper imental studies of model systems such as in vitro cell culture or animal models for functional interpreta tion of genome sequence variants (60) .
Animal models have long been applied in different studies for the investigation of biologi cal and pathogenical mechanisms, as well as for the development of effective treatment. Depend ing on the purpose of study, different animal mod els can be used, although the mouse (Mus musculus), the fruit fly (Drosophila melanogaster), and the zebra fish (Danio rerio) are the most common ly used in functional genome studies. This study has numerous advantages. For example, mutation can be induced artificially and the mutant pheno type can be recognized easily, genes can be cloned using standard procedures, the animal produces a large number of offspring in a relatively short period of time (61) . There are two main strategies of using animal model: "knock out" -suppression of the gene of interest, "knock in" -incorporation of the same mutation that is observed in a human. For instance, a number of studies have been con ducted for creating animal models of human dis eases by chemical mutagenesis (e. g., Nethyl ni trosourea; ENU) that causes random allelic point mutations in mice. However, the major limitation of animal models is the phenotype that often does not reflect human beings (62, 63) .
At this very moment, a promising technology for obtaining more information about human diseases is the CRISPRCas9 (Clustered Regu larly Interspaced Short Polindromic Repeats/ CRISPRassociated) system, which was found to be a prokaryotic immune system against viruses. This system consists of a small cluster of cas genes (encoding CRISPR associated proteins) and spe cific DNA sequence, called CRISPR locus, which comprises short repeats that are separated by unique spacers (64) . During a virus infection, its unique spacer integrates into the bacterial CRIS PR locus. Subsequently, this locus is transcribed into precursor CRISPR RNA (precrRNA). After the processing, the mature crRNA can recognize and destroy target nucleic acid by interacting with Cas proteins (65) . So CRISPR locus contains in formation about previous virus infections, thus giving an opportunity for bacteria to recognize and inactivate the virus in case of reinfection. Currently, some scientific studies show that it is possible to engineer the protein and RNA com ponents of bacterial CRISPR system in order to recognize and cut DNA at the desired locus (66) . Due to these properties, there is a possibility of applying this system in vitro in the human cell line, in order to study human diseases without any negative consequences (67) .
CONCLUSIONS
It is believed that successful functional genome analysis discovers genetic basic for human health by filling the gaps in knowledge about pathogen ic pathways between genes, proteins, and their interaction network. There are a lot of different methods and tools for accurate functional anal ysis. Despite huge analytical progress, these me thods have certain limitations (see the Table) . Thus, in order to extend the limits of current tech niques, some highthroughput technologies such as quantitative realtime poly merase chain reac tion, nextgeneration sequencing or mass spec trometry have been developed, which provide an opportunity to perform genomewide func tional analysis. Furthermore, model systems such as CRISPRCas9 or animal models are required for an extensive functional interpretation of ge nome sequence variants. However, in processing large amounts of data researchers are still facing the problem, that usually is very complicated and time consuming. For this reason, there is a need of continuous improvement in technology and development of more efficient analytical tools. It should be noted that for more comprehensive re sults it is essential to use complex methodologies that complement each other's shortcomings. 
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